Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...
China has set an ambitious target of “around 5%” growth for 2025, in a defiant show of confidence as it braces for the ...
Growth outlooks in the United States and several other countries are projected to slow this year and next, as uncertainty on ...
President Donald Trump's tariff hikes will drag down growth in Canada, Mexico and the United States while driving up ...
The German luxury carmaker said net profits tanked by more than a third last year, and warned that 2025 was also likely to be ...
China's imports unexpectedly shrank over the January-February period, while exports lost momentum, as escalating tariff ...
ostensibly imposed over China's failure to curb shipments of fentanyl precursors—a claim Beijing dismisses as a pretext for protectionism—add to longstanding tensions over unfair trade practices.
The inconsistent trade policy coming from Washington leaves Beijing with no clear path to take to get out of the crosshairs.
Meanwhile, rival Haleon, which makes Advil, Night Nurse and Panadol, told Reuters in late February that most of Haleon's U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback